Rs 2,700 cancer drug selling for Rs 27,000: Supreme Court calls it daylight robbery
The Supreme Court has described the steep markup on essential cancer medicines as “daylight robbery” after being told that a drug available to retailers for Rs 2,700 carried a maximum retail price of Rs 27,000.
India Today4 个来源阅读 1 分钟归档于2026年9月22日